4

4Basebio PLC
LSE:4BB

Watchlist Manager
4Basebio PLC
LSE:4BB
Watchlist
Price: 615 GBX Market Closed
Market Cap: 95.6m GBX

Wall Street
Price Targets

4BB Price Targets Summary
4Basebio PLC

Wall Street analysts forecast 4BB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 4BB is 1 734 GBX with a low forecast of 1 616 GBX and a high forecast of 1 890 GBX.

Lowest
Price Target
1 616 GBX
163% Upside
Average
Price Target
1 734 GBX
182% Upside
Highest
Price Target
1 890 GBX
207% Upside
4Basebio PLC Competitors:
Price Targets
002252
Shanghai RAAS Blood Products Co Ltd
11% Upside
2480
Beijing Luzhu Biotechnology Co Ltd
34% Upside
AMGN
Amgen Inc
1% Upside
ACAD
ACADIA Pharmaceuticals Inc
8% Upside
4974
Takara Bio Inc
41% Upside
ORKA
Oruka Therapeutics Inc
58% Upside
BIOCON
Biocon Ltd
12% Upside
300896
Imeik Technology Development Co Ltd
38% Upside

Revenue
Forecast

Revenue Estimate
4Basebio PLC

For the last 4 years the compound annual growth rate for 4Basebio PLC's revenue is 19%. The projected CAGR for the next 4 years is 131%.

19%
Past Growth
131%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Operating Income
Forecast

Operating Income Estimate
4Basebio PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
4Basebio PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 4BB's stock price target?
Price Target
1 734 GBX

According to Wall Street analysts, the average 1-year price target for 4BB is 1 734 GBX with a low forecast of 1 616 GBX and a high forecast of 1 890 GBX.

What is 4Basebio PLC's Revenue forecast?
Projected CAGR
131%

For the last 4 years the compound annual growth rate for 4Basebio PLC's revenue is 19%. The projected CAGR for the next 4 years is 131%.

Back to Top